NASDAQ:RVPH

Reviva Pharmaceuticals Holdings Stock Forecast

etoro logo Buy RVPH
*Your capital is at risk
$0.595
-0.0050 (-0.83%)
At Close: Jun 02, 2026
AI Analysis AI Analysis of RVPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RVPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Reviva Pharmaceuticals Holdings, Inc. stock price on Tuesday moving 25.00% between high and low
(Updated on Jun 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 02, 2026

The Reviva Pharmaceuticals Holdings, Inc. stock price fell by -0.83% on the last day (Tuesday, 2nd Jun 2026) from $0.600 to $0.595. During the last trading day the stock fluctuated 25.00% from a day low at $0.520 to a day high of $0.650. The price has risen in 5 of the last 10 days and is up by 47.83% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -213 thousand shares and in total, 71 thousand shares were bought and sold for approximately $42.48 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

RVPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, May 13, 2026, and so far it has risen 68.99%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Reviva Pharmaceuticals Holdings, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.690. On a fall, the stock will find some support from the short-term average at $0.462. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Reviva Pharmaceuticals Holdings, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 25.00%. For the last week the stock has had daily average volatility of 31.21%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RVPH) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Reviva Pharmaceuticals Holdings, Inc. to open at $0.588, and during the day (based on 14 day Average True Range), to move between $0.541 and $0.649, which gives a possible trading interval of +/-$0.109 (+/-20.12%) up or down from last closing price. If Reviva Pharmaceuticals Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 20.12% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.660, some $0.0650 (10.92%) from the current price of $0.595, our system finds the risk reward not very attractive.

Is Reviva Pharmaceuticals Holdings, Inc. stock A Buy?

Reviva Pharmaceuticals Holdings, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.140 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 3, 2026 - $0.588 ( 1.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RVPH Performance

Trading levels for RVPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.718 20.73%
R2 0.669 12.38%
R1 0.638 7.23%
Price 0.595
S1 0.539 -9.47%
S2 0.508 -14.62%
S3 0.458 -22.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.720 21.01%
R2 0.712 19.66%
R1 0.660 10.92%
Price 0.595
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Reviva Pharmaceuticals Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Reviva Pharmaceuticals Holdings, Inc. is RVPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Reviva Pharmaceuticals Holdings, Inc. Stock?
Reviva Pharmaceuticals Holdings, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Reviva Pharmaceuticals Holdings, Inc. Stock?
Reviva Pharmaceuticals Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Reviva Pharmaceuticals Holdings, Inc. Stock.

What's the current price of Reviva Pharmaceuticals Holdings, Inc. Stock?
As of the end of day on the Jun 02, 2026, the price of an Reviva Pharmaceuticals Holdings, Inc. (RVPH) share was $0.595.

What is the 52-week high and low for Reviva Pharmaceuticals Holdings, Inc. Stock?
The 52-week high for Reviva Pharmaceuticals Holdings, Inc. Stock is $19.00 and the 52-week low is $0.262.

What is the market capitalization of Reviva Pharmaceuticals Holdings, Inc. Stock?
As of the Jun 02, 2026, the market capitalization of Reviva Pharmaceuticals Holdings, Inc. is 2.028M.

When is the next earnings date for Reviva Pharmaceuticals Holdings, Inc.?
The upcoming earnings date for Reviva Pharmaceuticals Holdings, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT REVIVA PHARMACEUTICALS HOLDINGS, INC.
Reviva Pharmaceuticals Holdings
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE